Vir Biotechnology Inc (VIR) — Capital Reinvestment Ratio
Latest as of December 2022:
0.36x
Vir Biotechnology Inc (VIR) has a Capital Reinvestment Ratio of 0.36x as of December 2022, meaning it reinvests 0% of its operating cash flow ($35.13 Million) in capital expenditures ($12.60 Million). See free cash flow generation of Vir Biotechnology Inc to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.36x
Capex / Operating Cash Flow
Operating Cash Flow
$35.13 Million
USD
Capital Expenditures
$12.60 Million
USD
Data as of
Dec 2022
Most recent filing
Vir Biotechnology Inc Capital Reinvestment Ratio (2022–2022)
This chart tracks Vir Biotechnology Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Vir Biotechnology Inc (2022–2022)
Year-by-year Capital Reinvestment Ratio for Vir Biotechnology Inc from 2022 to 2022. For live market cap and broader valuation context, see market cap of Vir Biotechnology Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.04x | $1.66 Billion | $68.01 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow